CuraSen Therapeutics
Latest round
- Series A
Last raised
- Oct 2021
Total raised
- $45M
Investors
- 6
About CuraSen Therapeutics
Founded in 2017 and based in California, US, CuraSen Therapeutics, Inc. is a biopharmaceutical company that advances science to improve the lives of patients suffering from debilitating conditions like Parkinson's and Alzheimer's diseases. Anthony Ford (CEO), Kathleen Sereda Glaub, Mehrdad Shamloo, and Robert Booth are the co-founders of the company. In October 2023, CuraSen Therapeutics, Inc. The company’s product pipeline features a range of therapeutic candidates, primarily centered around adrenergic receptor agonists, which are designed to address both cognitive symptoms and disease progression in neurodegenerative conditions. It’s product pipeline encompasses ß2-AR Agonist, which consists of CST-103/CST-107 (clenbuterol/nadolol), which is a fixed-dose combination in development for Parkinson's disease, specifically targeting cognitive symptoms and disease progression; and CST-2032/CST-107 (nadolol), which addresses cognitive symptoms and disease progression in Alzheimer's disease. The firm also develops a1A-AR Agonist, which comprises CST-2140, which is designed to treat neurogenic orthostatic hypotension (nOH), a condition characterized by a sharp drop in blood pressure upon standing commonly associated with Parkinsonism, and CST-3056, which is being developed for broader neurodegenerative diseases. CuraSen's drugs mainly focus on restoring locus coeruleus, a part of the brain that synthesizes norepinephrine in the human body, since its degeneration serves as the main reason for Alzheimer’s and Parkinson’s diseases.
Who invested in CuraSen Therapeutics
6 investors across 2 rounds
See all investors in CuraSen Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CuraSen Therapeutics
Who invested in CuraSen Therapeutics?
CuraSen Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CuraSen Therapeutics raised?
CuraSen Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did CuraSen Therapeutics last raise money?
CuraSen Therapeutics's most recent round on record is a Series A, in Oct 2021.
What does CuraSen Therapeutics do?
Founded in 2017 and based in California, US, CuraSen Therapeutics, Inc.
Where is CuraSen Therapeutics headquartered?
CuraSen Therapeutics is headquartered in San Carlos, US.
Which VCs invest in companies like CuraSen Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CuraSen Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like CuraSen Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.